Your browser doesn't support javascript.
loading
Substrate specificity of HMRZ-86 for beta-lactamases, including extended-spectrum beta-lactamases (ESBLs).
Hanaki, Hideaki; Koide, Yuuji; Yamazaki, Hiroaki; Kubo, Ryoichi; Nakano, Tomota; Atsuda, Koichiro; Sunakawa, Keisuke.
Afiliação
  • Hanaki H; Research Center for Anti-Infective Drugs, Kitasato Institute, Minato-ku, Tokyo, Japan.
J Infect Chemother ; 13(6): 390-5, 2007 Dec.
Article em En | MEDLINE | ID: mdl-18095087
ABSTRACT
HMRZ-86 was designed as a new chromogenic cephalosporin to detect extended-spectrum beta-lactamases (ESBLs) and similar evolved beta-lactamases, such as metallo-beta-lactamases, derepressed AmpC, and extended oxacillinase. We report here our investigation of the kinetic parameters of several types of beta-lactamases to show the enzymatic characteristics of HMRZ-86. The Michaelis constant (Km values of HMRZ-86 for ESBLs were twice to three and half times as high as those of nitrocefin, and the maximum velocity (Vmax) was one-fifth that of nitrocefin. The Km and Vmax of HMRZ-86 for AmpC were both smaller than those of nitrocefin. The kinetic parameters of HMRZ-86 for metallo beta-lactamase (MBL) were very variable, depending on the type of buffer solution used and the concentration of zinc ions. For MBL, the Km values of HMRZ-86 were higher than those of nitrocefin, but the Vmax values were almost the same as those of nitrocefin. Although the chemical structure of HMRZ-86 is similar to that of nitrocefin, we think the enzymatic reactivities of the two entities for beta-lactamases are very different.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Beta-Lactamases / Cefalosporinas / Antibacterianos Limite: Humans Idioma: En Revista: J Infect Chemother Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2007 Tipo de documento: Article País de afiliação: Japão
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Beta-Lactamases / Cefalosporinas / Antibacterianos Limite: Humans Idioma: En Revista: J Infect Chemother Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2007 Tipo de documento: Article País de afiliação: Japão